Return to study ST001075 main page
MB Sample ID: SA072522
Local Sample ID: | SB10 |
Subject ID: | SU001119 |
Subject Type: | Mammal |
Subject Species: | Rattus norvegicus |
Taxonomy ID: | 10116 |
Genotype Strain: | F344/Ntac-Apc-+/Pirc |
Age Or Age Range: | 30 |
Animal Animal Supplier: | Taconic and Envigo |
Animal Housing: | Conventional, |
Animal Feed: | Labdiet 5058 |
Animal Water: | Autoclaved, purified with sulfuric acid |
Select appropriate tab below to view additional metadata details:
Subject:
Subject ID: | SU001119 |
Subject Type: | Mammal |
Subject Species: | Rattus norvegicus |
Taxonomy ID: | 10116 |
Genotype Strain: | F344/Ntac-Apc-+/Pirc |
Age Or Age Range: | 30 |
Animal Animal Supplier: | Taconic and Envigo |
Animal Housing: | Conventional, |
Animal Feed: | Labdiet 5058 |
Animal Water: | Autoclaved, purified with sulfuric acid |
Factors:
Local Sample ID | MB Sample ID | Factor Level ID | Level Value | Factor Name |
---|---|---|---|---|
SB10 | SA072522 | FL011376 | GM;SD | Group |
Collection:
Collection ID: | CO001113 |
Collection Summary: | Fecal samples collected at 1 month of age, prior to any observable disease onset. F344 refers to Fisher (F344) rats, whereas as GM:SD refers to the GM from Sprague-Dawley rats, while GM:LEW refers to the gut microbiota (GM) from Lewis rats |
Collection Protocol ID: | 8732 |
Sample Type: | Feces |
Collection Method: | Sterile, asceptic method. Animals were placed in clean, sterile cages and feces were speared with sterile, autoclaved toothpicks. |
Collection Location: | Discovery Ridge, Columbia MO |
Storage Conditions: | -80℃ |
Collection Vials: | Glass |
Storage Vials: | Glass |
Treatment:
Treatment ID: | TR001133 |
Treatment Summary: | Pirc rats were rederived using 3 surrogate dams, each with distinct gut microbiota profiles |
Treatment Protocol ID: | 8732 |
Sample Preparation:
Sampleprep ID: | SP001126 |
Sampleprep Summary: | Fecal samples were lyophilized at -20 ˚C using 0.1 millibar of vacuum pressure, following which dried samples (30 mg) were extracted sequentially for both UHPLC-MS and GC-MS. The dried samples were first treated with 1.0 mL of 80% MeOH containing 18 µg/mL umbelliferone, sonicated for 5 minutes and centrifuged for 40 minutes at 3000 g at 10 ºC. 0.5 mL of supernatant was used for UHPLC-MS analysis after a subsequent spin at 5000 g at 10 ºC for 20 minutes and transferring 250 µL of the sample into glass autosampler vials with inserts. For GC-MS (Gas Chromatography-Mass Spectrometry) analyses of primary polar metabolites, 0.5 mL water was added the remaining extract used above for the UHPLC preparation, sonicated for 5 min, extracted for 30min, and centrifuged at 3000 g. 0.5 mL of the polar extract was subsequently dried under nitrogen and derivatized using previously established protocols (84). Briefly, N-Methyl-N-(trimethylsilyl) trifluoroacetamide (MSTFA) with 1 % TMCS (2,2,2-Trifluoro-N-methyl-N-(trimethylsilyl)-acetamide, Chlorotrimethylsilane) was used to derivatize the polar metabolites, after treatment with methoxyamine-HCl-pyridine. |
Combined analysis:
Analysis ID | AN001757 |
---|---|
Analysis type | MS |
Chromatography type | Reversed phase |
Chromatography system | Agilent 1290 |
Column | Waters Acquity BEH C18 (150 x 2.1mm,1.7um) |
MS Type | ESI |
MS instrument type | QTOF |
MS instrument name | Bruker maXis Impact qTOF |
Ion Mode | NEGATIVE |
Units | Peak Area |
Chromatography:
Chromatography ID: | CH001241 |
Instrument Name: | Agilent 1290 |
Column Name: | Waters Acquity BEH C18 (150 x 2.1mm,1.7um) |
Chromatography Type: | Reversed phase |
MS:
MS ID: | MS001625 |
Analysis ID: | AN001757 |
Instrument Name: | Bruker maXis Impact qTOF |
Instrument Type: | QTOF |
MS Type: | ESI |
Ion Mode: | NEGATIVE |